Basit öğe kaydını göster

dc.contributor.authorOc, Mehmet
dc.contributor.authorUcar, Halil Ibrahim
dc.contributor.authorPinar, Asil
dc.contributor.authorAkbulut, Birkan
dc.contributor.authorOc, Bahar
dc.contributor.authorAkinci, Seda Banu
dc.contributor.authorAkyon, Yakut
dc.contributor.authorKanbak, Meral
dc.contributor.authorBoke, Erkmen
dc.contributor.authorDogan, Riza
dc.date.accessioned2019-12-12T06:24:51Z
dc.date.available2019-12-12T06:24:51Z
dc.date.issued2007
dc.identifier.issn0379-5284
dc.identifier.urihttps://doi.org/
dc.identifier.urihttp://hdl.handle.net/11655/16214
dc.description.abstractObjective: To examined the pre- and post-operative anti-HSP60 antibodies of serum from patients in preoperative sinus rhythm. Methods: We prospectively studied 45 consecutive patients admitted for elective CABG from 2004 to 2005. We randomly selected 10 patients developing AF (study sample [Group A]) and 10 postoperative patients without AF (control [Group B]. The study took place at the Department of Cardiovascular Surgery, Hacettepe University, Ankara, Turkey. Results: Anti-HSP60 IgG value was 27.76 +/- 12.69 absorbance units (AU) in Group A preoperatively and decreased to 13.73 +/- 5.51 AU postoperatively. Controversially, preoperative value of anti-HSP60 IgG was 9.94 +/- 2.92 AU and decreased to 6.72 +/- 1.89 AU, postoperatively in Group B. Statistical analysis showed significant difference regarding preoperative anti-HSP60 IgG levels in Group A compared to Group B, which might be interpreted as an association between postoperative AF and preoperative levels of anti-HSP60 IgG. Conclusion: We provide the first evidence demonstrating the association of pre- and post-operative circulating anti-HSP60 antibodies with postoperative AF. These results suggest that serum HSP60 antibody levels may be a marker for subsequent development of AF.
dc.language.isoen
dc.publisherSaudi Med J
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectGeneral & Internal Medicine
dc.titleHeat Shock Protein 60 Antibody - A New Marker For Subsequent Atrialfibrillation Development
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.relation.journalSaudi Medical Journal
dc.contributor.departmentTıbbi Biyokimya
dc.identifier.volume28
dc.identifier.issue6
dc.identifier.startpage844
dc.identifier.endpage847
dc.description.indexWoS


Bu öğenin dosyaları:

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster